Dacima Consulting   Report issue

For profit Phase 3 Phase 4
Founded: Berges du Lac Tunisia (2015)

Organization Overview

First Clinical Trial
2018
NCT03329261
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dacima Consulting | DACIMA Software

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Infections (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Virus Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6